These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 4831267)

  • 1. [Glucose tolerance, insulin secretion, levels of free fatty acids and growth hormone in hepatic cirrhosis].
    Marañón A; Durán S; Sanjose G; Romero E
    Rev Clin Esp; 1974 Feb; 132(4):299-306. PubMed ID: 4831267
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carbohydrate metabolism in liver diseases].
    Mosin VI
    Klin Med (Mosk); 1974 Feb; 52(2):. PubMed ID: 4619410
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease.
    Hernandez A; Zorrilla E; Gershberg H
    J Lab Clin Med; 1969 Jan; 73(1):25-33. PubMed ID: 5762161
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin and somatotropic hormone secretion and connective tissue function in patients with chronic hepatitis and liver cirrhosis].
    Okorokov AN
    Ter Arkh; 1984; 56(2):67-71. PubMed ID: 6369610
    [No Abstract]   [Full Text] [Related]  

  • 5. [Secretion of insulin and growth hormone during glucagon loading in obesity].
    Masuda K; Chikamori K; Hirano M; Fujinaka S; Tetsuka U
    Horumon To Rinsho; 1974 Jul; 22(7):847-52. PubMed ID: 4473056
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dynamic exploration of carbohydrate metabolism in liver cirrhosis. Determination of free fatty acids and insulin in the blood].
    Perreau P; Joubaud F; Cheguillaume J; Boyer J; Vernin H
    Sem Hop; 1972 Mar; 48(14):957-66. PubMed ID: 4339074
    [No Abstract]   [Full Text] [Related]  

  • 7. [Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis].
    Descos L; M'Bendi S; Sassolas G; Audigier JC; Sidiqian N; Faure A; Bizollon CA
    Arch Fr Mal App Dig; 1974; 63(1):17-24. PubMed ID: 4441222
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 9. Potassium depletion in hepatic cirrhosis. A reversible cause of impaired growth-hormone and insulin response to stimulation.
    Podolsky S; Zimmerman HJ; Burrows BA; Cardarelli JA; Pattavina CG
    N Engl J Med; 1973 Mar; 288(13):644-8. PubMed ID: 4687256
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of long-term infusion of glucagon on carbohydrate metabolism, insulin and growth hormone secretion in patients with congestive heart failure.
    Frey HM; Falch D; Forfang K; Norman N; Fremstad D
    Diabetes; 1972 Sep; 21(9):939-45. PubMed ID: 5055720
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of growth hormone on glucose, nonesterified fatty acid and insulin levels, and on glucose utilization in dairy calves.
    Head HH; Ventura M; Webb DW; Wilcox CJ
    J Dairy Sci; 1970 Oct; 53(10):1496-501. PubMed ID: 5528764
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of carbohydrate metabolism in postnecrotic cirrhosis liver.
    Yeung RT; Wang CC
    Gut; 1974 Nov; 15(11):907-12. PubMed ID: 4455570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of growth hormone on plasma glucose, NEFA, insulin and blood pyruvate levels during intravenous glucose tolerance tests.
    Doar JW; Maw DS; Simpson RD; Audhya TK; Wynn V
    J Endocrinol; 1969 Sep; 45(1):137-8. PubMed ID: 5357884
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in carbohydrate metabolism, plasmatic NEFA and immunoreactive insulin in hepatic cirrhosis].
    Gragnoli G; Pupillo A; Montagnani M; Bayeli PF
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1373-90. PubMed ID: 5759915
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disturbances of carbohydrate regulation in hepatic lesions].
    Magnenat P
    Helv Med Acta; 1970 Dec; 35(5):354-62. PubMed ID: 5501843
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbohydrate metabolism in patients with primary hepatocellular carcinoma.
    Vinik AI; Pooler W
    Clin Sci Mol Med; 1973 Sep; 45(3):387-96. PubMed ID: 4361808
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of fenfluramine on insulin and growth hormone secretion.
    Cabezas-Cerrato J; Casanueva F; Villanueva L; Gómez M; Camarero E
    Arch Farmacol Toxicol; 1978 Aug; 4(2):227-36. PubMed ID: 727835
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia.
    Colwell JA; Wilber JF
    Diabetes; 1971 Sep; 20(9):607-14. PubMed ID: 4328691
    [No Abstract]   [Full Text] [Related]  

  • 19. Physiological and clinical aspects of circadian variations in glucose tolerance.
    Wojtczak-Jaroszowa J
    Chronobiologia; 1977; 4(4):363-84. PubMed ID: 350522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of corticosteroids on insulin and growth hormone secretion].
    Durán S; Marañón A; Romero E
    Rev Clin Esp; 1974 Jan; 132(1):41-6. PubMed ID: 4600559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.